TOKYO -- IBM Japan and the University of Tokyo will work together to devise the most effective cancer treatments for individual patients using artificial intelligence, the first such attempt in Asia.
IBM Japan will collect the latest medical research and drug data from across the world on its state-of-the-art supercomputer Watson. The system has the cognitive ability to read language texts, allowing it to process an enormous amount of data in a very short period of time.
By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our
to learn how you can update your cookie settings.